Loading viewer...
investor_presentation
Format: PDF investor_presentation
Tillotts Pharma AG is a pharmaceutical company with a portfolio of gastrointestinal and inflammatory products including Asacol, Colpermin, and Entocort. The presentation covers company overview, leadership, product offerings, vision, and organizational culture. Established with presence across multiple countries, Tillotts focuses on innovative treatments in gastroenterology.
investor_presentation
34 Pages
ASMI
BriaCell Therapeutics Investor Presentation 2021
investor_presentationinvestor_presentation
17 Pages
BriaCell Therapeutics Corp.